Hu Q - Search Results

1

Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species.

Zou J, Jiang C, Hu Q, Jia X, Wang S, Wan S, Mao Y, Zhang D, Zhang P, Dai B, Li Y. Zou J, et al. Among authors: hu q. Nat Commun. 2025 Jan 6;16(1):424. doi: 10.1038/s41467-024-55658-0. Nat Commun. 2025. PMID: 39762214 Free PMC article.

2

ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells.

Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, Qin Y, Zhang L, Zhang P. Hu Q, et al. Cancer Res. 2023 May 15;83(10):1646-1665. doi: 10.1158/0008-5472.CAN-22-1999. Cancer Res. 2023. PMID: 36892426

3

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.

Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, Yu X, Xu J. Sun Q, et al. Among authors: hu q. Theranostics. 2018 Oct 6;8(18):5072-5087. doi: 10.7150/thno.26546. eCollection 2018. Theranostics. 2018. PMID: 30429887 Free PMC article. Review.

4

The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context.

Xing F, Hu Q, Qin Y, Xu J, Zhang B, Yu X, Wang W. Xing F, et al. Among authors: hu q. Front Oncol. 2022 Apr 22;12:862743. doi: 10.3389/fonc.2022.862743. eCollection 2022. Front Oncol. 2022. PMID: 35530337 Free PMC article. Review.

5

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1.

Wang T, Hu Q, Li B, Fan G, Jing D, Xu J, Hu Y, Dang Q, Ji S, Zhou C, Zhuo Q, Xu X, Qin Y, Yu X, Li Z. Wang T, et al. Among authors: hu y, hu q. Cell Prolif. 2024 Nov;57(11):e13694. doi: 10.1111/cpr.13694. Epub 2024 Jun 27. Cell Prolif. 2024. PMID: 38938061 Free PMC article.

6

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer.

Hu Q, Qin Y, Xiang J, Liu W, Xu W, Sun Q, Ji S, Liu J, Zhang Z, Ni Q, Xu J, Yu X, Zhang B. Hu Q, et al. Cell Prolif. 2018 Aug;51(4):e12456. doi: 10.1111/cpr.12456. Epub 2018 Apr 27. Cell Prolif. 2018. PMID: 29701272 Free PMC article.

7

Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells.

Zhang Z, Xu H, He J, Hu Q, Liu Y, Xu Z, Lou W, Wu W, Zhang L, Pu N, Shi C, Xu Y, Wang W, Liu L. Zhang Z, et al. Among authors: hu q. Cell Death Dis. 2025 Jan 18;16(1):28. doi: 10.1038/s41419-025-07330-8. Cell Death Dis. 2025. PMID: 39827156 Free PMC article.

8

FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer.

Zhang Z, Qin Y, Ji S, Xu W, Liu M, Hu Q, Ye Z, Fan G, Yu X, Liu W, Xu X. Zhang Z, et al. Among authors: hu q. Acta Biochim Biophys Sin (Shanghai). 2021 Jul 28;53(8):997-1008. doi: 10.1093/abbs/gmab074. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 34117747 Free article.

9

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.

Hu Q, Qin Y, Zhang B, Liang C, Ji S, Shi S, Xu W, Xiang J, Liang D, Ni Q, Yu X, Xu J. Hu Q, et al. Oncol Rep. 2017 Oct;38(4):2069-2077. doi: 10.3892/or.2017.5856. Epub 2017 Jul 28. Oncol Rep. 2017. PMID: 28765935 Free PMC article.

10

Cancer immunometabolism: advent, challenges, and perspective.

Dang Q, Li B, Jin B, Ye Z, Lou X, Wang T, Wang Y, Pan X, Hu Q, Li Z, Ji S, Zhou C, Yu X, Qin Y, Xu X. Dang Q, et al. Among authors: hu q. Mol Cancer. 2024 Apr 5;23(1):72. doi: 10.1186/s12943-024-01981-5. Mol Cancer. 2024. PMID: 38581001 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,282 results

Search Page

Filters